Generation BioÂ Co (GBIO) Financials

$5.34

$-0.40 (-6.97%)

As on 10-Feb-2026 09:30EDT

Market cap

$36 Mln

Revenue (TTM)

$15 Mln

P/E Ratio

--

P/B Ratio

0.7

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Operating Revenue	15.27	19.89	5.90	0.88	--	--
Cost of Revenue	1.40	4.93	5.26	5.13	4.53	3.43
Gross Profit	13.87	19.89	5.90	-5.13	-4.53	-3.43
Operating Expenses	98.45	162.28	144.47	141.18	119.10	81.11
Operating Profit (EBIT)	-84.58	-142.39	-138.56	-141.18	-119.10	-81.11
Other Income	--	--	--	4.54	-0.05	0.59
Profit before Tax	-62.63	-131.67	-126.61	-136.64	-119.15	-80.52
Provision for Tax	--	--	5.10	-4.54	-4.48	-4.02
Profit after Tax (Net Income)	-62.63	-131.67	-126.61	-132.10	-114.67	-76.50
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	-136.64	-119.15	-80.52

Liabilities ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Shareholder's Funds	50.56	86.20	203.13	282.49	381.75	268.01
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	50.30	109.94	131.72	74.62	76.22	14.92
Current Liabilities	21.04	35.06	39.91	19.15	18.81	11.22
Total Liabilities	142.94	231.20	374.76	376.26	476.77	294.16

Assets ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Non-Current Assets	28.43	38.29	102.14	89.25	97.59	26.42
Current Assets	93.46	192.90	272.62	287.02	379.19	267.74
Total Assets	142.94	231.20	374.76	376.26	476.77	294.16
Total Debt*	26.10	93.56	97.89	81.71	80.83	--
Net Current Assets	72.42	157.85	232.70	267.87	360.38	256.52

Cashflow ($ Mln)	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Cash From Operating Activities	--	-88.56	-52.75	-102.45	-91.82	-70.14
Cash Flow from Investing Activities	--	94.53	-9.70	-192.52	193.05	-205.20
Cash from Financing Activities	--	0.25	35.82	12.99	214.67	323.10
Net Cash Inflow / Outflow	--	--	--	-281.97	315.90	47.76

Financials Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Adjusted EPS ($)	-9.35	-19.73	-1.96	-22.24	-20.16	-16.68
Cash EPS ($)	--	-18.99	-1.88	-21.37	-19.36	-15.93
Adjusted Book Value ($)	--	12.92	3.15	47.55	67.11	58.45
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-13.27	-0.82	-17.25	-16.14	-15.30
Free Cash Flow per Share ($)	--	-13.63	-0.93	-18.73	-17.19	-16.50

Profitability Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
ROCE (%)	--	-54.77	-38.07	-31.95	-31.39	-90.31
ROE (%)	-101.10	-91.02	-52.14	-39.77	-35.30	-90.31
ROA (%)	-29.69	-43.46	-33.72	-30.97	-29.75	-45.50
EBIT Margin (%)	-414.88	-398.11	-2,346.93	-16,043.41	--	--
Net Margin (%)	-410.13	-661.91	-2,144.51	-2,435.85	229,338.00	-12,944.16
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Revenue Growth (%)	-17.82	2.37	5.71	--	--	--
EBIT Growth (%)	35.12	42.85	1.86	-18.54	-46.83	-30.19
Net Profit Growth (%)	56.95	-3.99	4.15	-15.20	-49.89	-26.80
EPS Growth (%)	45.40	-9.05	0.91	-0.10	-0.21	0.13
Book Value Growth (%)	-52.03	--	--	--	--	--

Valuation Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Price / Earnings	--	-0.05	-0.84	-0.18	-0.35	-1.70
Price / Book Value	0.71	0.08	0.52	0.08	0.11	0.49
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-0.34	1.14	0.45	1.28	2.22	1.70
Close Price ($)	6.12	10.60	16.50	39.30	70.80	283.50
High Price ($)	27.40	46.50	73.50	95.90	418.60	557.20
Low Price ($)	3.00	7.50	8.60	35.45	55.00	170.00
Market Cap ($ Cr)	35.98	--	--	--	--	--

Solvency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debt to Equity	--	1.09	0.48	0.29	0.21	--
Short term debt to equity ratio	0.13	0.15	0.04	0.03	0.01	0.01
Current Ratio	4.44	5.50	6.83	14.99	20.16	23.86
Quick Ratio	4.44	--	6.73	--	--	--
Interest Coverage	--	--	-11.59	-31.08	-2,382.02	-137.25

Operating Efficiency Ratios	TTM	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15
Debtors to sales (%)	2.56	7.84	70.26	75.00	--	--
Asset Turnover	0.07	0.07	0.02	0.00	--	--
Receivable days	--	52.39	148.72	220.60	--	--
Inventory Days	--	282.66	264.83	--	--	0.00
Payable days	--	139.03	104.38	95.58	92.28	133.99
Cash Conversion Cycle	--	196.02	309.17	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.